Carmel Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $504K | Sell |
646
-3
| -0.5% | -$2.34K | 0.18% | 88 |
|
|
2025
Q1 | $536K | Buy |
649
+20
| +3% | +$16.5K | 0.21% | 85 |
|
|
2024
Q4 | $486K | Buy |
629
+20
| +3% | +$15.4K | 0.2% | 83 |
|
|
2024
Q3 | $540K | Sell |
609
-4
| -0.7% | -$3.55K | 0.21% | 81 |
|
|
2024
Q2 | $555K | Buy |
613
+4
| +0.7% | +$3.62K | 0.23% | 73 |
|
|
2024
Q1 | $474K | Sell |
609
-101
| -14% | -$78.6K | 0.2% | 76 |
|
|
2023
Q4 | $414K | Sell |
710
-245
| -26% | -$143K | 0.21% | 82 |
|
|
2023
Q3 | $513K | Buy |
955
+352
| +58% | +$189K | 0.23% | 75 |
|
|
2023
Q2 | $283K | Buy |
603
+4
| +0.7% | +$1.88K | 0.15% | 96 |
|
|
2023
Q1 | $206K | Hold |
599
| – | – | 0.12% | 124 |
|
|
2022
Q4 | $219K | Buy |
+599
| New | +$219K | 0.15% | 120 |
|